Deal Library / Pharma BD Deal Intelligence

Sumitomo Dainippon Pharma Co., Ltd. — Pharma Deals

The Pharma Closeout tracks 4 deals, $4.7B in disclosed deal value, 2 with a post-close Outcome Score for Sumitomo Dainippon Pharma Co., Ltd..

Median Critic Score: 75  ·  Median Outcome Score: 26

Best outcome: Sumitomo Dainippon Pharma Co., Ltd. / Cynapsus Therapeutics Inc. (28)  ·  Weakest outcome: Sumitomo Dainippon Pharma Co., Ltd. / Tolero Pharmaceuticals, Inc. (24)

All 4 deals

• Sumitomo Dainippon Pharma Co., Ltd. / Cynapsus Therapeutics Inc. — 2016 · $624M · Did not work — the deal failed to deliver.
• Sumitomo Dainippon Pharma Co., Ltd. / Tolero Pharmaceuticals, Inc. — 2016 · $780M · Did not work — the deal failed to deliver.
• Sumitomo Dainippon Pharma Co., Ltd. / Otsuka Pharmaceutical Co., Ltd. — 2021 · $270M
• Sumitomo Dainippon Pharma Co., Ltd. / Roivant Sciences Ltd. (Sumitovant five-Vant deal) — 2019 · $3.0B

← Deal Library  ·  Interactive search  ·  How we score deals